Results 111 to 120 of about 2,217 (170)

Considerations for Streamlining the Pathway Toward Approval of a Cognition Enhancer for Schizophrenia. [PDF]

Schizophr Bull
Nuechterlein KH, Green MF, Marder SR.
europepmc   +1 more source

Optimized <i>Ginkgo biloba</i> extract EGb 761^®: boosted therapeutic benefits with minimized CYP enzyme interference. [PDF]

J Pharm Pharm Sci
Kwon S, Jeong S, Lee S.
europepmc   +1 more source

Neurocognitive effects of proanthocyanidin in Alzheimer's disease: a systematic review of preclinical evidence. [PDF]

Braz J Med Biol Res
Reshma A, Subramanian A, Kumarasamy V, Tamilanban T, Sekar M, Gan SH, Subramaniyan V, Wong LS, Rani NNIM, Wu YS.   +9 more
europepmc   +1 more source

Causal effect of conventional anti-dementia drugs on economic burden: an orthogonal double/debiased machine learning approach. [PDF]

BMC Geriatr
Jiang X, Lv G, Franklin J, Li M, Lu ZK.
europepmc   +1 more source

Inhibitor-Free Variant of the Cheung Regimen: Successful Adjunctive Therapy in Long-Standing Hypochondriasis With Prominent Somatic Features. [PDF]

Cureus
Cheung N.
europepmc   +1 more source

Effect of acupuncture on vascular cognitive impairment (VCI): A randomized controlled trial. [PDF]

Medicine (Baltimore)
Bai L, Cheng HL, Zhang WD, Hu PJ, Xu FY, Liu YQ, Dai F, Zhang LY.   +7 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Current Trends in the Animal Models for Screening of Nootropic Agents: A Systematic Review

Current Reviews in Clinical and Experimental Pharmacology, 2023
Background:Deficits in cognitive functions are observed in various diseases. The term “nootropics” refers to the compounds that increase mental functions, including memory, motivation, concentration and attention. Given the complexity and vastness of the processes involved in cognition, developing an appropriate animal model for the screening of ...
Seema Jain, Shubhima Grover
exaly   +3 more sources

Nootropic agents stimulate neurogenesis

Expert Opinion on Therapeutic Patents, 2009
The application is in the field of adult neurogenesis, neural stem cells and cellular therapy. It aims to characterize the activity of nootropic agents on adult neurogenesis in vitro. Nootropic agents are substances improving cognitive and mental abilities. AMPA (alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate) and nootropic agents were assessed
Philippe Taupin
exaly   +3 more sources

EFFECT OF NOOTROPIC AGENTS ON BRAIN CHOLINERGIC MECHANISMS

Clinical Neuropharmacology, 1984
Flavio Moroni
exaly   +3 more sources

Nootropic agents

Side Effects of Drugs Annual
exaly   +2 more sources